Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17700046rdf:typepubmed:Citationlld:pubmed
pubmed-article:17700046lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:17700046lifeskim:mentionsumls-concept:C0003289lld:lifeskim
pubmed-article:17700046lifeskim:mentionsumls-concept:C1269683lld:lifeskim
pubmed-article:17700046lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:17700046lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:17700046lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:17700046pubmed:issue5lld:pubmed
pubmed-article:17700046pubmed:dateCreated2007-8-16lld:pubmed
pubmed-article:17700046pubmed:abstractTextWhether the dose of antidepressants can be reduced following clinical improvement without subsequently increasing the likelihood of depressive relapse has not been established. Thus, the aim of this work was to compare relapse rates among patients with major depressive disorder (MDD) randomized to either continue receiving the full versus a reduced dose of antidepressants following partial or full improvement of symptoms.lld:pubmed
pubmed-article:17700046pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17700046pubmed:languageenglld:pubmed
pubmed-article:17700046pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17700046pubmed:citationSubsetIMlld:pubmed
pubmed-article:17700046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17700046pubmed:statusMEDLINElld:pubmed
pubmed-article:17700046pubmed:issn0033-3190lld:pubmed
pubmed-article:17700046pubmed:authorpubmed-author:PapakostasGeo...lld:pubmed
pubmed-article:17700046pubmed:authorpubmed-author:FavaMaurizioMlld:pubmed
pubmed-article:17700046pubmed:authorpubmed-author:PerlisRoy HRHlld:pubmed
pubmed-article:17700046pubmed:authorpubmed-author:SeifertCheryl...lld:pubmed
pubmed-article:17700046pubmed:copyrightInfo2007 S. Karger AG, Basellld:pubmed
pubmed-article:17700046pubmed:issnTypePrintlld:pubmed
pubmed-article:17700046pubmed:volume76lld:pubmed
pubmed-article:17700046pubmed:ownerNLMlld:pubmed
pubmed-article:17700046pubmed:authorsCompleteYlld:pubmed
pubmed-article:17700046pubmed:pagination266-70lld:pubmed
pubmed-article:17700046pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:17700046pubmed:meshHeadingpubmed-meshheading:17700046...lld:pubmed
pubmed-article:17700046pubmed:meshHeadingpubmed-meshheading:17700046...lld:pubmed
pubmed-article:17700046pubmed:meshHeadingpubmed-meshheading:17700046...lld:pubmed
pubmed-article:17700046pubmed:meshHeadingpubmed-meshheading:17700046...lld:pubmed
pubmed-article:17700046pubmed:meshHeadingpubmed-meshheading:17700046...lld:pubmed
pubmed-article:17700046pubmed:meshHeadingpubmed-meshheading:17700046...lld:pubmed
pubmed-article:17700046pubmed:meshHeadingpubmed-meshheading:17700046...lld:pubmed
pubmed-article:17700046pubmed:meshHeadingpubmed-meshheading:17700046...lld:pubmed
pubmed-article:17700046pubmed:year2007lld:pubmed
pubmed-article:17700046pubmed:articleTitleAntidepressant dose reduction and the risk of relapse in major depressive disorder.lld:pubmed
pubmed-article:17700046pubmed:affiliationDepression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, Mass. 02114, USA. gpapakostas@partners.orglld:pubmed
pubmed-article:17700046pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17700046pubmed:publicationTypeMeta-Analysislld:pubmed
pubmed-article:17700046pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17700046lld:pubmed